References
- Blaser MJ. Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992;102:720–7.
- Satoh K, Kimura K, Taniguchi Y, Yoshida Y, Kihira K, Takimoto T. Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. Am J Gastroenterol 1996;9:963–9.
- Furuta T, Baba S, Takashima M, Futami H, Arai H, Kajimura M, et al. Effect of Helicobacter pylori infection on gastric juice pH. Scand J Gastroenterol 1998;33:357–63.
- Mobley HL. The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration. Aliment Pharmacol Ther 1996;10 Suppl 1:57–64.
- Beil W, Birkholz C, Wagner S, Sewing KF. Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric H+/K+ -ATPase. Gut 1994;35:1176–80.
- Jablonowski H, Hengels KJ, Kraemer N, Geis G, Opferkuch W, Strohmeyer G. Effects of Helicobacter pylori on histamine and carbachol stimulated acid secretion by human parietal cells. Gut 1994;35:755–7.
- Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994;29:425–9.
- Kondo S, Shinomura Y, Kanayama S, Kawabata S, Miyazaki Y, Imamura I, et al. Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am J Physiol 1994;267:G966–71.
- Logan RP, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12–6.
- Houben GM, Stockbrugger RW. Bacteria in the aetio-pathogenesis of gastric cancer: a review. Scand J Gastroenterol 1995;30 Suppl 212:13–8.